Stratos Wealth Partners LTD. Raises Stake in SPDR S&P Biotech ETF (XBI)

Stratos Wealth Partners LTD. lifted its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.4% during the 1st quarter, HoldingsChannel reports. The firm owned 16,554 shares of the exchange traded fund’s stock after buying an additional 543 shares during the period. Stratos Wealth Partners LTD.’s holdings in SPDR S&P Biotech ETF were worth $1,499,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of XBI. JPMorgan Chase & Co. increased its stake in shares of SPDR S&P Biotech ETF by 98.7% during the third quarter. JPMorgan Chase & Co. now owns 3,265,715 shares of the exchange traded fund’s stock worth $313,084,000 after buying an additional 1,622,372 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of SPDR S&P Biotech ETF by 15.7% during the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 6,635 shares of the exchange traded fund’s stock worth $601,000 after buying an additional 900 shares during the period. Elite Wealth Management Inc. increased its stake in shares of SPDR S&P Biotech ETF by 1.8% during the fourth quarter. Elite Wealth Management Inc. now owns 9,065 shares of the exchange traded fund’s stock worth $650,000 after buying an additional 160 shares during the period. Tocqueville Asset Management L.P. increased its stake in shares of SPDR S&P Biotech ETF by 65.1% during the fourth quarter. Tocqueville Asset Management L.P. now owns 149,590 shares of the exchange traded fund’s stock worth $10,733,000 after buying an additional 58,960 shares during the period. Finally, Foresters Investment Management Company Inc. increased its stake in SPDR S&P Biotech ETF by 22.1% in the fourth quarter. Foresters Investment Management Company Inc. now owns 63,500 shares of the exchange traded fund’s stock valued at $4,556,000 after purchasing an additional 11,500 shares during the last quarter.

Shares of SPDR S&P Biotech ETF stock opened at $82.56 on Friday. SPDR S&P Biotech ETF has a 52 week low of $64.38 and a 52 week high of $101.55.

WARNING: “Stratos Wealth Partners LTD. Raises Stake in SPDR S&P Biotech ETF (XBI)” was published by Baseball Daily News and is the sole property of of Baseball Daily News. If you are viewing this article on another website, it was illegally stolen and reposted in violation of US & international copyright law. The legal version of this article can be viewed at https://www.baseballdailydigest.com/news/2019/05/19/stratos-wealth-partners-ltd-raises-stake-in-spdr-sp-biotech-etf-xbi.html.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

See Also: What is the CBOE Russell 2000® Volatility Index?

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.